SynthesisPloS one2016

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.

George W Rutherford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.